X
LEO Pharma acquires Bayer’s dermatology unit
https://pharmaphorum.com/news/leo-pharma-acquires-bayers-dermatology-unit/
dermatology
FDA approves UCB’s Cimzia in plaque psoriasis
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
The Microbiome Movement – Skin Health & Dermatology Summit Has Arrived
Join The Microbiome Movement
Boehringer pins hopes on novel psoriasis drug
Immune disorder drug is highlight of pipeline
Sanofi makes double EU filing for cancer and asthma drugs
But NICE rejects Dupixent in eczema